Avidity Biosciences, Inc. / Fundamentals
Income statement
- Net revenue
€9.21M - Cost of goods sold
€698.41K - Gross profit
€8.51M - SG&A expenses
€104.74M - R&D expenses
€352.16M - EBITDA
-€445.77M - D&A
€2.61M - EBIT
-€447.69M - Interest expenses
€0.00 - EBT
-€391.03M - Tax expenses
€0.00 - Net income
-€391.03M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€9.20M - Changes in working capital
-€69.99M - Operating cash flow
-€420.40M - Capex
€10.91M - Other investing cash flow
€0.00 - Net investing cash flow
-€174.96M - Total cash dividends paid
€0.00 - Issuance of common stock
€280.59M - Debt repayment
€0.00 - Other financing cash flow
€29.92M - Net financing cash flow
€310.51M - Foreign exchange effects
€132.13K - Net change in cash
-€284.72M - Cash at end of period
€211.67M - Free cash flow
-€409.49M
Balance sheet
- Cash and cash equivalents
€209.27M - Cash and short-term investments
€1.02B - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€57.84M - Total current assets
€1.07B - Property, plant & equipment
€21.25M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€2.40M - Other non-current assets
€77.91M - Total non-current assets
€101.56M - Total assets
€1.17B - Accounts payable
€3.36M - Short-term debt
€3.37M - Other current liabilities
€97.54M - Total current liabilities
€115.88M - Long-term debt
€2.08M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€34.31M - Total non-current liabilities
€35.35M - Total liabilities
€151.23M - Common stock
€10.30K - Retained earnings
-€1.00B - Other equity
€1.52M - Total equity
€1.02B - Total liabilities and shareholders' equity
€1.17B
Company information
- Market capitalization
€2.98B - Employees
391 - Enterprise Value
€3.80B
Company ratios
- Gross margin
-
92.4% Much better than peer group: -462.4% - EBITDA margin
-
-4,842.5% Much better than peer group: -7,868.6% - EBIT margin
-
-4,863.3% Much better than peer group: -8,537.9% - EBT margin
-
-4,247.8% Much better than peer group: -8,177.5% - Net margin
-
-4,247.8% Much better than peer group: -8,088.6% - ROE
-
-38.2% Much better than peer group: -100.2% - ROA
-
-33.3% Better than peer group: -45.5% - Asset turnover
-
0.8% Worse than peer group: 6.1% - FCF margin
-
-4,685.4% Much better than peer group: -6,289.1% - FCF yield
-14.5% - Efficiency ratio
4,942.5% - Net sales per employee
-
€23.54K - Net income per employee
-
-€1.00M